225 related articles for article (PubMed ID: 27712587)
1. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway.
Lu Q; Liu Z; Li Z; Chen J; Liao Z; Wu WR; Li YW
Oncol Res; 2016; 24(5):305-313. PubMed ID: 27712587
[TBL] [Abstract][Full Text] [Related]
2. TIPE2 inhibits PDGF-BB-induced phenotype switching in airway smooth muscle cells through the PI3K/Akt signaling pathway.
Wang H; Zhong B; Geng Y; Hao J; Jin Q; Zhang Y; Dong L; Gao D; Li J; Hou W
Respir Res; 2021 Aug; 22(1):238. PubMed ID: 34446024
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
4. TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.
Wang L; Chen C; Feng S; Tian J
Mol Med Rep; 2018 May; 17(5):7017-7026. PubMed ID: 29568863
[TBL] [Abstract][Full Text] [Related]
5. Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway.
Zhan K; Liu R; Tong H; Gao S; Yang G; Hossain A; Li T; He W
Biomed Pharmacother; 2020 Nov; 131():110689. PubMed ID: 32892030
[TBL] [Abstract][Full Text] [Related]
6. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.
Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M
Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498
[TBL] [Abstract][Full Text] [Related]
7. TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways.
Zhang Z; Liu L; Liu C; Cao S; Zhu Y; Mei Q
Oncol Rep; 2016 Dec; 36(6):3311-3316. PubMed ID: 27779698
[TBL] [Abstract][Full Text] [Related]
8. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
9. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.
Tan Y; Yao H; Hu J; Liu L
Oncol Res; 2017 Sep; 25(8):1253-1259. PubMed ID: 28160462
[TBL] [Abstract][Full Text] [Related]
11. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
[TBL] [Abstract][Full Text] [Related]
12. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor (TNF)-α-Induced Protein 8-like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.
Wang K; Ren Y; Liu Y; Zhang J; He JJ
Oncol Res; 2017 Jan; 25(1):55-63. PubMed ID: 28081733
[TBL] [Abstract][Full Text] [Related]
14. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
15. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
16. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
[TBL] [Abstract][Full Text] [Related]
17. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.
Ye J; Gao M; Guo X; Zhang H; Jiang F
Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672
[TBL] [Abstract][Full Text] [Related]
18. TIPE2 Inhibits Hypoxia-Induced Wnt/β-Catenin Pathway Activation and EMT in Glioma Cells.
Liu ZJ; Liu HL; Zhou HC; Wang GC
Oncol Res; 2016; 24(4):255-61. PubMed ID: 27656836
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling.
Zhu Y; Tao M; Wu J; Meng Y; Xu C; Tian Y; Zhou X; Xiang J; Zhang H; Xie Y
Cancer Gene Ther; 2016 Apr; 23(4):98-106. PubMed ID: 26987289
[TBL] [Abstract][Full Text] [Related]
20. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
